| 1 |
30630678 | The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China. | 2019 Apr |
6 |
| 2 |
27098059 | Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. | 2016 Oct |
2 |
| 3 |
26176234 | Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. | 2015 |
3 |
| 4 |
26495850 | Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. | 2015 |
1 |
| 5 |
24917585 | A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives. | 2014 Sep |
3 |
| 6 |
22047493 | Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes. | 2011 Dec |
1 |
| 7 |
20007295 | Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites. | 2010 Mar |
4 |
| 8 |
16480962 | Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4. | 2006 Apr 28 |
1 |
| 9 |
16884532 | Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants. | 2006 |
4 |
| 10 |
15135306 | Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4. | 2004 Jun 1 |
4 |